Pharma & Healthcare
Humira Biosimilar - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Nov 05, 24
- ID: 660541
- Pages: 123
- Figures: 236
- Views: 8
Humira is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
The global market for Humira Biosimilar was estimated to be worth US$ 421 million in 2023 and is forecast to a readjusted size of US$ 958.9 million by 2030 with a CAGR of 12.5% during the forecast period 2024-2030
The introduction of Humira biosimilars is expected to increase competition in the market, leading to lower prices and improved access to treatment for patients. The availability of biosimilars provides an alternative option for healthcare providers and payers to choose from, potentially reducing the overall healthcare expenditure associated with biologic treatments.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Humira Biosimilar, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Humira Biosimilar by region & country, by Type, and by Application.
The Humira Biosimilar market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Humira Biosimilar.
Market Segmentation
By Company
Cadila Healthcare
Torrent Pharmaceuticals
Amgen
Boehringer Ingelheim
Novartis
Samsung Bioepis
Viatris
Pfizer
Fresenius Kabi
Coherus
Segment by Type:
Syringe
Pen
Segment by Application
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Humira Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Humira Biosimilar in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Humira Biosimilar in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Humira Biosimilar was estimated to be worth US$ 421 million in 2023 and is forecast to a readjusted size of US$ 958.9 million by 2030 with a CAGR of 12.5% during the forecast period 2024-2030
The introduction of Humira biosimilars is expected to increase competition in the market, leading to lower prices and improved access to treatment for patients. The availability of biosimilars provides an alternative option for healthcare providers and payers to choose from, potentially reducing the overall healthcare expenditure associated with biologic treatments.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Humira Biosimilar, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Humira Biosimilar by region & country, by Type, and by Application.
The Humira Biosimilar market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Humira Biosimilar.
Market Segmentation
By Company
Cadila Healthcare
Torrent Pharmaceuticals
Amgen
Boehringer Ingelheim
Novartis
Samsung Bioepis
Viatris
Pfizer
Fresenius Kabi
Coherus
Segment by Type:
Syringe
Pen
Segment by Application
Ankylosing Spondylitis
Rheumatoid Arthritis
Crohn’s Disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Humira Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Humira Biosimilar in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Humira Biosimilar in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Humira Biosimilar Product Introduction
1.2 Global Humira Biosimilar Market Size Forecast
1.2.1 Global Humira Biosimilar Sales Value (2019-2030)
1.2.2 Global Humira Biosimilar Sales Volume (2019-2030)
1.2.3 Global Humira Biosimilar Sales Price (2019-2030)
1.3 Humira Biosimilar Market Trends & Drivers
1.3.1 Humira Biosimilar Industry Trends
1.3.2 Humira Biosimilar Market Drivers & Opportunity
1.3.3 Humira Biosimilar Market Challenges
1.3.4 Humira Biosimilar Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Humira Biosimilar Players Revenue Ranking (2023)
2.2 Global Humira Biosimilar Revenue by Company (2019-2024)
2.3 Global Humira Biosimilar Players Sales Volume Ranking (2023)
2.4 Global Humira Biosimilar Sales Volume by Company Players (2019-2024)
2.5 Global Humira Biosimilar Average Price by Company (2019-2024)
2.6 Key Manufacturers Humira Biosimilar Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Humira Biosimilar Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Humira Biosimilar
2.9 Humira Biosimilar Market Competitive Analysis
2.9.1 Humira Biosimilar Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Humira Biosimilar Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humira Biosimilar as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Syringe
3.1.2 Pen
3.2 Global Humira Biosimilar Sales Value by Type
3.2.1 Global Humira Biosimilar Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Humira Biosimilar Sales Value, by Type (2019-2030)
3.2.3 Global Humira Biosimilar Sales Value, by Type (%) (2019-2030)
3.3 Global Humira Biosimilar Sales Volume by Type
3.3.1 Global Humira Biosimilar Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Humira Biosimilar Sales Volume, by Type (2019-2030)
3.3.3 Global Humira Biosimilar Sales Volume, by Type (%) (2019-2030)
3.4 Global Humira Biosimilar Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Ankylosing Spondylitis
4.1.2 Rheumatoid Arthritis
4.1.3 Crohn’s Disease
4.1.4 Other
4.2 Global Humira Biosimilar Sales Value by Application
4.2.1 Global Humira Biosimilar Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Humira Biosimilar Sales Value, by Application (2019-2030)
4.2.3 Global Humira Biosimilar Sales Value, by Application (%) (2019-2030)
4.3 Global Humira Biosimilar Sales Volume by Application
4.3.1 Global Humira Biosimilar Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Humira Biosimilar Sales Volume, by Application (2019-2030)
4.3.3 Global Humira Biosimilar Sales Volume, by Application (%) (2019-2030)
4.4 Global Humira Biosimilar Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Humira Biosimilar Sales Value by Region
5.1.1 Global Humira Biosimilar Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Humira Biosimilar Sales Value by Region (2019-2024)
5.1.3 Global Humira Biosimilar Sales Value by Region (2025-2030)
5.1.4 Global Humira Biosimilar Sales Value by Region (%), (2019-2030)
5.2 Global Humira Biosimilar Sales Volume by Region
5.2.1 Global Humira Biosimilar Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Humira Biosimilar Sales Volume by Region (2019-2024)
5.2.3 Global Humira Biosimilar Sales Volume by Region (2025-2030)
5.2.4 Global Humira Biosimilar Sales Volume by Region (%), (2019-2030)
5.3 Global Humira Biosimilar Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Humira Biosimilar Sales Value, 2019-2030
5.4.2 North America Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Humira Biosimilar Sales Value, 2019-2030
5.5.2 Europe Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Humira Biosimilar Sales Value, 2019-2030
5.6.2 Asia Pacific Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Humira Biosimilar Sales Value, 2019-2030
5.7.2 South America Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Humira Biosimilar Sales Value, 2019-2030
5.8.2 Middle East & Africa Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Humira Biosimilar Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Humira Biosimilar Sales Value
6.2.1 Key Countries/Regions Humira Biosimilar Sales Value, 2019-2030
6.2.2 Key Countries/Regions Humira Biosimilar Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Humira Biosimilar Sales Value, 2019-2030
6.3.2 United States Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Humira Biosimilar Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Humira Biosimilar Sales Value, 2019-2030
6.4.2 Europe Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Humira Biosimilar Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Humira Biosimilar Sales Value, 2019-2030
6.5.2 China Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
6.5.3 China Humira Biosimilar Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Humira Biosimilar Sales Value, 2019-2030
6.6.2 Japan Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Humira Biosimilar Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Humira Biosimilar Sales Value, 2019-2030
6.7.2 South Korea Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Humira Biosimilar Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Humira Biosimilar Sales Value, 2019-2030
6.8.2 Southeast Asia Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Humira Biosimilar Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Humira Biosimilar Sales Value, 2019-2030
6.9.2 India Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
6.9.3 India Humira Biosimilar Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Cadila Healthcare
7.1.1 Cadila Healthcare Company Information
7.1.2 Cadila Healthcare Introduction and Business Overview
7.1.3 Cadila Healthcare Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Cadila Healthcare Humira Biosimilar Product Offerings
7.1.5 Cadila Healthcare Recent Development
7.2 Torrent Pharmaceuticals
7.2.1 Torrent Pharmaceuticals Company Information
7.2.2 Torrent Pharmaceuticals Introduction and Business Overview
7.2.3 Torrent Pharmaceuticals Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Torrent Pharmaceuticals Humira Biosimilar Product Offerings
7.2.5 Torrent Pharmaceuticals Recent Development
7.3 Amgen
7.3.1 Amgen Company Information
7.3.2 Amgen Introduction and Business Overview
7.3.3 Amgen Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Amgen Humira Biosimilar Product Offerings
7.3.5 Amgen Recent Development
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Company Information
7.4.2 Boehringer Ingelheim Introduction and Business Overview
7.4.3 Boehringer Ingelheim Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Boehringer Ingelheim Humira Biosimilar Product Offerings
7.4.5 Boehringer Ingelheim Recent Development
7.5 Novartis
7.5.1 Novartis Company Information
7.5.2 Novartis Introduction and Business Overview
7.5.3 Novartis Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Novartis Humira Biosimilar Product Offerings
7.5.5 Novartis Recent Development
7.6 Samsung Bioepis
7.6.1 Samsung Bioepis Company Information
7.6.2 Samsung Bioepis Introduction and Business Overview
7.6.3 Samsung Bioepis Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Samsung Bioepis Humira Biosimilar Product Offerings
7.6.5 Samsung Bioepis Recent Development
7.7 Viatris
7.7.1 Viatris Company Information
7.7.2 Viatris Introduction and Business Overview
7.7.3 Viatris Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Viatris Humira Biosimilar Product Offerings
7.7.5 Viatris Recent Development
7.8 Pfizer
7.8.1 Pfizer Company Information
7.8.2 Pfizer Introduction and Business Overview
7.8.3 Pfizer Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Pfizer Humira Biosimilar Product Offerings
7.8.5 Pfizer Recent Development
7.9 Fresenius Kabi
7.9.1 Fresenius Kabi Company Information
7.9.2 Fresenius Kabi Introduction and Business Overview
7.9.3 Fresenius Kabi Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Fresenius Kabi Humira Biosimilar Product Offerings
7.9.5 Fresenius Kabi Recent Development
7.10 Coherus
7.10.1 Coherus Company Information
7.10.2 Coherus Introduction and Business Overview
7.10.3 Coherus Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Coherus Humira Biosimilar Product Offerings
7.10.5 Coherus Recent Development
8 Industry Chain Analysis
8.1 Humira Biosimilar Industrial Chain
8.2 Humira Biosimilar Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Humira Biosimilar Sales Model
8.5.2 Sales Channel
8.5.3 Humira Biosimilar Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Humira Biosimilar Product Introduction
1.2 Global Humira Biosimilar Market Size Forecast
1.2.1 Global Humira Biosimilar Sales Value (2019-2030)
1.2.2 Global Humira Biosimilar Sales Volume (2019-2030)
1.2.3 Global Humira Biosimilar Sales Price (2019-2030)
1.3 Humira Biosimilar Market Trends & Drivers
1.3.1 Humira Biosimilar Industry Trends
1.3.2 Humira Biosimilar Market Drivers & Opportunity
1.3.3 Humira Biosimilar Market Challenges
1.3.4 Humira Biosimilar Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Humira Biosimilar Players Revenue Ranking (2023)
2.2 Global Humira Biosimilar Revenue by Company (2019-2024)
2.3 Global Humira Biosimilar Players Sales Volume Ranking (2023)
2.4 Global Humira Biosimilar Sales Volume by Company Players (2019-2024)
2.5 Global Humira Biosimilar Average Price by Company (2019-2024)
2.6 Key Manufacturers Humira Biosimilar Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Humira Biosimilar Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Humira Biosimilar
2.9 Humira Biosimilar Market Competitive Analysis
2.9.1 Humira Biosimilar Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Humira Biosimilar Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humira Biosimilar as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Syringe
3.1.2 Pen
3.2 Global Humira Biosimilar Sales Value by Type
3.2.1 Global Humira Biosimilar Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Humira Biosimilar Sales Value, by Type (2019-2030)
3.2.3 Global Humira Biosimilar Sales Value, by Type (%) (2019-2030)
3.3 Global Humira Biosimilar Sales Volume by Type
3.3.1 Global Humira Biosimilar Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Humira Biosimilar Sales Volume, by Type (2019-2030)
3.3.3 Global Humira Biosimilar Sales Volume, by Type (%) (2019-2030)
3.4 Global Humira Biosimilar Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Ankylosing Spondylitis
4.1.2 Rheumatoid Arthritis
4.1.3 Crohn’s Disease
4.1.4 Other
4.2 Global Humira Biosimilar Sales Value by Application
4.2.1 Global Humira Biosimilar Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Humira Biosimilar Sales Value, by Application (2019-2030)
4.2.3 Global Humira Biosimilar Sales Value, by Application (%) (2019-2030)
4.3 Global Humira Biosimilar Sales Volume by Application
4.3.1 Global Humira Biosimilar Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Humira Biosimilar Sales Volume, by Application (2019-2030)
4.3.3 Global Humira Biosimilar Sales Volume, by Application (%) (2019-2030)
4.4 Global Humira Biosimilar Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Humira Biosimilar Sales Value by Region
5.1.1 Global Humira Biosimilar Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Humira Biosimilar Sales Value by Region (2019-2024)
5.1.3 Global Humira Biosimilar Sales Value by Region (2025-2030)
5.1.4 Global Humira Biosimilar Sales Value by Region (%), (2019-2030)
5.2 Global Humira Biosimilar Sales Volume by Region
5.2.1 Global Humira Biosimilar Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Humira Biosimilar Sales Volume by Region (2019-2024)
5.2.3 Global Humira Biosimilar Sales Volume by Region (2025-2030)
5.2.4 Global Humira Biosimilar Sales Volume by Region (%), (2019-2030)
5.3 Global Humira Biosimilar Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Humira Biosimilar Sales Value, 2019-2030
5.4.2 North America Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Humira Biosimilar Sales Value, 2019-2030
5.5.2 Europe Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Humira Biosimilar Sales Value, 2019-2030
5.6.2 Asia Pacific Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Humira Biosimilar Sales Value, 2019-2030
5.7.2 South America Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Humira Biosimilar Sales Value, 2019-2030
5.8.2 Middle East & Africa Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Humira Biosimilar Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Humira Biosimilar Sales Value
6.2.1 Key Countries/Regions Humira Biosimilar Sales Value, 2019-2030
6.2.2 Key Countries/Regions Humira Biosimilar Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Humira Biosimilar Sales Value, 2019-2030
6.3.2 United States Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Humira Biosimilar Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Humira Biosimilar Sales Value, 2019-2030
6.4.2 Europe Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Humira Biosimilar Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Humira Biosimilar Sales Value, 2019-2030
6.5.2 China Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
6.5.3 China Humira Biosimilar Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Humira Biosimilar Sales Value, 2019-2030
6.6.2 Japan Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Humira Biosimilar Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Humira Biosimilar Sales Value, 2019-2030
6.7.2 South Korea Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Humira Biosimilar Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Humira Biosimilar Sales Value, 2019-2030
6.8.2 Southeast Asia Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Humira Biosimilar Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Humira Biosimilar Sales Value, 2019-2030
6.9.2 India Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
6.9.3 India Humira Biosimilar Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Cadila Healthcare
7.1.1 Cadila Healthcare Company Information
7.1.2 Cadila Healthcare Introduction and Business Overview
7.1.3 Cadila Healthcare Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Cadila Healthcare Humira Biosimilar Product Offerings
7.1.5 Cadila Healthcare Recent Development
7.2 Torrent Pharmaceuticals
7.2.1 Torrent Pharmaceuticals Company Information
7.2.2 Torrent Pharmaceuticals Introduction and Business Overview
7.2.3 Torrent Pharmaceuticals Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Torrent Pharmaceuticals Humira Biosimilar Product Offerings
7.2.5 Torrent Pharmaceuticals Recent Development
7.3 Amgen
7.3.1 Amgen Company Information
7.3.2 Amgen Introduction and Business Overview
7.3.3 Amgen Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Amgen Humira Biosimilar Product Offerings
7.3.5 Amgen Recent Development
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Company Information
7.4.2 Boehringer Ingelheim Introduction and Business Overview
7.4.3 Boehringer Ingelheim Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Boehringer Ingelheim Humira Biosimilar Product Offerings
7.4.5 Boehringer Ingelheim Recent Development
7.5 Novartis
7.5.1 Novartis Company Information
7.5.2 Novartis Introduction and Business Overview
7.5.3 Novartis Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Novartis Humira Biosimilar Product Offerings
7.5.5 Novartis Recent Development
7.6 Samsung Bioepis
7.6.1 Samsung Bioepis Company Information
7.6.2 Samsung Bioepis Introduction and Business Overview
7.6.3 Samsung Bioepis Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Samsung Bioepis Humira Biosimilar Product Offerings
7.6.5 Samsung Bioepis Recent Development
7.7 Viatris
7.7.1 Viatris Company Information
7.7.2 Viatris Introduction and Business Overview
7.7.3 Viatris Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Viatris Humira Biosimilar Product Offerings
7.7.5 Viatris Recent Development
7.8 Pfizer
7.8.1 Pfizer Company Information
7.8.2 Pfizer Introduction and Business Overview
7.8.3 Pfizer Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Pfizer Humira Biosimilar Product Offerings
7.8.5 Pfizer Recent Development
7.9 Fresenius Kabi
7.9.1 Fresenius Kabi Company Information
7.9.2 Fresenius Kabi Introduction and Business Overview
7.9.3 Fresenius Kabi Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Fresenius Kabi Humira Biosimilar Product Offerings
7.9.5 Fresenius Kabi Recent Development
7.10 Coherus
7.10.1 Coherus Company Information
7.10.2 Coherus Introduction and Business Overview
7.10.3 Coherus Humira Biosimilar Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Coherus Humira Biosimilar Product Offerings
7.10.5 Coherus Recent Development
8 Industry Chain Analysis
8.1 Humira Biosimilar Industrial Chain
8.2 Humira Biosimilar Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Humira Biosimilar Sales Model
8.5.2 Sales Channel
8.5.3 Humira Biosimilar Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Humira Biosimilar Market Trends
Table 2. Humira Biosimilar Market Drivers & Opportunity
Table 3. Humira Biosimilar Market Challenges
Table 4. Humira Biosimilar Market Restraints
Table 5. Global Humira Biosimilar Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Humira Biosimilar Revenue Market Share by Company (2019-2024)
Table 7. Global Humira Biosimilar Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Humira Biosimilar Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Humira Biosimilar Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Humira Biosimilar Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Humira Biosimilar Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Humira Biosimilar
Table 13. Global Humira Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humira Biosimilar as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Humira Biosimilar Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Humira Biosimilar Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Humira Biosimilar Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Humira Biosimilar Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Humira Biosimilar Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Humira Biosimilar Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Humira Biosimilar Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Humira Biosimilar Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Humira Biosimilar Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Humira Biosimilar Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Humira Biosimilar Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Humira Biosimilar Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Humira Biosimilar Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Humira Biosimilar Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Humira Biosimilar Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Humira Biosimilar Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Humira Biosimilar Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Humira Biosimilar Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Humira Biosimilar Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Humira Biosimilar Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Humira Biosimilar Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Humira Biosimilar Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Humira Biosimilar Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Humira Biosimilar Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Humira Biosimilar Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Humira Biosimilar Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Humira Biosimilar Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Humira Biosimilar Sales Value by Region (2019-2024) & (%)
Table 44. Global Humira Biosimilar Sales Value by Region (2025-2030) & (%)
Table 45. Global Humira Biosimilar Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Humira Biosimilar Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Humira Biosimilar Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Humira Biosimilar Sales Volume by Region (2019-2024) & (%)
Table 49. Global Humira Biosimilar Sales Volume by Region (2025-2030) & (%)
Table 50. Global Humira Biosimilar Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Humira Biosimilar Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Humira Biosimilar Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Humira Biosimilar Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Humira Biosimilar Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Humira Biosimilar Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Humira Biosimilar Sales Volume, (2025-2030) & (K Units)
Table 57. Cadila Healthcare Company Information
Table 58. Cadila Healthcare Introduction and Business Overview
Table 59. Cadila Healthcare Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Cadila Healthcare Humira Biosimilar Product Offerings
Table 61. Cadila Healthcare Recent Development
Table 62. Torrent Pharmaceuticals Company Information
Table 63. Torrent Pharmaceuticals Introduction and Business Overview
Table 64. Torrent Pharmaceuticals Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Torrent Pharmaceuticals Humira Biosimilar Product Offerings
Table 66. Torrent Pharmaceuticals Recent Development
Table 67. Amgen Company Information
Table 68. Amgen Introduction and Business Overview
Table 69. Amgen Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Amgen Humira Biosimilar Product Offerings
Table 71. Amgen Recent Development
Table 72. Boehringer Ingelheim Company Information
Table 73. Boehringer Ingelheim Introduction and Business Overview
Table 74. Boehringer Ingelheim Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Boehringer Ingelheim Humira Biosimilar Product Offerings
Table 76. Boehringer Ingelheim Recent Development
Table 77. Novartis Company Information
Table 78. Novartis Introduction and Business Overview
Table 79. Novartis Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Novartis Humira Biosimilar Product Offerings
Table 81. Novartis Recent Development
Table 82. Samsung Bioepis Company Information
Table 83. Samsung Bioepis Introduction and Business Overview
Table 84. Samsung Bioepis Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Samsung Bioepis Humira Biosimilar Product Offerings
Table 86. Samsung Bioepis Recent Development
Table 87. Viatris Company Information
Table 88. Viatris Introduction and Business Overview
Table 89. Viatris Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Viatris Humira Biosimilar Product Offerings
Table 91. Viatris Recent Development
Table 92. Pfizer Company Information
Table 93. Pfizer Introduction and Business Overview
Table 94. Pfizer Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Pfizer Humira Biosimilar Product Offerings
Table 96. Pfizer Recent Development
Table 97. Fresenius Kabi Company Information
Table 98. Fresenius Kabi Introduction and Business Overview
Table 99. Fresenius Kabi Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Fresenius Kabi Humira Biosimilar Product Offerings
Table 101. Fresenius Kabi Recent Development
Table 102. Coherus Company Information
Table 103. Coherus Introduction and Business Overview
Table 104. Coherus Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Coherus Humira Biosimilar Product Offerings
Table 106. Coherus Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Humira Biosimilar Downstream Customers
Table 110. Humira Biosimilar Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Humira Biosimilar Product Picture
Figure 2. Global Humira Biosimilar Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Humira Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Humira Biosimilar Sales Volume (2019-2030) & (K Units)
Figure 5. Global Humira Biosimilar Sales Price (2019-2030) & (US$/Unit)
Figure 6. Humira Biosimilar Report Years Considered
Figure 7. Global Humira Biosimilar Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Humira Biosimilar Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Humira Biosimilar Revenue in 2023
Figure 10. Humira Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Syringe Picture
Figure 12. Pen Picture
Figure 13. Global Humira Biosimilar Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Humira Biosimilar Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Humira Biosimilar Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Humira Biosimilar Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Humira Biosimilar Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Ankylosing Spondylitis
Figure 19. Product Picture of Rheumatoid Arthritis
Figure 20. Product Picture of Crohn’s Disease
Figure 21. Product Picture of Other
Figure 22. Global Humira Biosimilar Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Humira Biosimilar Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Humira Biosimilar Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 25. Global Humira Biosimilar Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Humira Biosimilar Price by Application (2019-2030) & (US$/Unit)
Figure 27. North America Humira Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Humira Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Humira Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Humira Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Humira Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Humira Biosimilar Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Humira Biosimilar Sales Volume (%), (2019-2030)
Figure 39. United States Humira Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Humira Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Humira Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Humira Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 45. China Humira Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 47. China Humira Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Humira Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Humira Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Humira Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Humira Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Humira Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Humira Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 57. India Humira Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 59. India Humira Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 60. Humira Biosimilar Industrial Chain
Figure 61. Humira Biosimilar Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Humira Biosimilar Market Trends
Table 2. Humira Biosimilar Market Drivers & Opportunity
Table 3. Humira Biosimilar Market Challenges
Table 4. Humira Biosimilar Market Restraints
Table 5. Global Humira Biosimilar Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Humira Biosimilar Revenue Market Share by Company (2019-2024)
Table 7. Global Humira Biosimilar Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Humira Biosimilar Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Humira Biosimilar Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Humira Biosimilar Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Humira Biosimilar Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Humira Biosimilar
Table 13. Global Humira Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humira Biosimilar as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Humira Biosimilar Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Humira Biosimilar Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Humira Biosimilar Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Humira Biosimilar Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Humira Biosimilar Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Humira Biosimilar Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Humira Biosimilar Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Humira Biosimilar Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Humira Biosimilar Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Humira Biosimilar Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Humira Biosimilar Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Humira Biosimilar Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Humira Biosimilar Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Humira Biosimilar Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Humira Biosimilar Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Humira Biosimilar Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Humira Biosimilar Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Humira Biosimilar Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Humira Biosimilar Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Humira Biosimilar Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Humira Biosimilar Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Humira Biosimilar Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Humira Biosimilar Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Humira Biosimilar Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Humira Biosimilar Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Humira Biosimilar Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Humira Biosimilar Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Humira Biosimilar Sales Value by Region (2019-2024) & (%)
Table 44. Global Humira Biosimilar Sales Value by Region (2025-2030) & (%)
Table 45. Global Humira Biosimilar Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Humira Biosimilar Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Humira Biosimilar Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Humira Biosimilar Sales Volume by Region (2019-2024) & (%)
Table 49. Global Humira Biosimilar Sales Volume by Region (2025-2030) & (%)
Table 50. Global Humira Biosimilar Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Humira Biosimilar Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Humira Biosimilar Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Humira Biosimilar Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Humira Biosimilar Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Humira Biosimilar Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Humira Biosimilar Sales Volume, (2025-2030) & (K Units)
Table 57. Cadila Healthcare Company Information
Table 58. Cadila Healthcare Introduction and Business Overview
Table 59. Cadila Healthcare Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Cadila Healthcare Humira Biosimilar Product Offerings
Table 61. Cadila Healthcare Recent Development
Table 62. Torrent Pharmaceuticals Company Information
Table 63. Torrent Pharmaceuticals Introduction and Business Overview
Table 64. Torrent Pharmaceuticals Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Torrent Pharmaceuticals Humira Biosimilar Product Offerings
Table 66. Torrent Pharmaceuticals Recent Development
Table 67. Amgen Company Information
Table 68. Amgen Introduction and Business Overview
Table 69. Amgen Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Amgen Humira Biosimilar Product Offerings
Table 71. Amgen Recent Development
Table 72. Boehringer Ingelheim Company Information
Table 73. Boehringer Ingelheim Introduction and Business Overview
Table 74. Boehringer Ingelheim Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Boehringer Ingelheim Humira Biosimilar Product Offerings
Table 76. Boehringer Ingelheim Recent Development
Table 77. Novartis Company Information
Table 78. Novartis Introduction and Business Overview
Table 79. Novartis Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Novartis Humira Biosimilar Product Offerings
Table 81. Novartis Recent Development
Table 82. Samsung Bioepis Company Information
Table 83. Samsung Bioepis Introduction and Business Overview
Table 84. Samsung Bioepis Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Samsung Bioepis Humira Biosimilar Product Offerings
Table 86. Samsung Bioepis Recent Development
Table 87. Viatris Company Information
Table 88. Viatris Introduction and Business Overview
Table 89. Viatris Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Viatris Humira Biosimilar Product Offerings
Table 91. Viatris Recent Development
Table 92. Pfizer Company Information
Table 93. Pfizer Introduction and Business Overview
Table 94. Pfizer Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Pfizer Humira Biosimilar Product Offerings
Table 96. Pfizer Recent Development
Table 97. Fresenius Kabi Company Information
Table 98. Fresenius Kabi Introduction and Business Overview
Table 99. Fresenius Kabi Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Fresenius Kabi Humira Biosimilar Product Offerings
Table 101. Fresenius Kabi Recent Development
Table 102. Coherus Company Information
Table 103. Coherus Introduction and Business Overview
Table 104. Coherus Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Coherus Humira Biosimilar Product Offerings
Table 106. Coherus Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Humira Biosimilar Downstream Customers
Table 110. Humira Biosimilar Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Humira Biosimilar Product Picture
Figure 2. Global Humira Biosimilar Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Humira Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Humira Biosimilar Sales Volume (2019-2030) & (K Units)
Figure 5. Global Humira Biosimilar Sales Price (2019-2030) & (US$/Unit)
Figure 6. Humira Biosimilar Report Years Considered
Figure 7. Global Humira Biosimilar Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Humira Biosimilar Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Humira Biosimilar Revenue in 2023
Figure 10. Humira Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Syringe Picture
Figure 12. Pen Picture
Figure 13. Global Humira Biosimilar Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Humira Biosimilar Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Humira Biosimilar Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Humira Biosimilar Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Humira Biosimilar Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Ankylosing Spondylitis
Figure 19. Product Picture of Rheumatoid Arthritis
Figure 20. Product Picture of Crohn’s Disease
Figure 21. Product Picture of Other
Figure 22. Global Humira Biosimilar Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Humira Biosimilar Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Humira Biosimilar Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 25. Global Humira Biosimilar Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Humira Biosimilar Price by Application (2019-2030) & (US$/Unit)
Figure 27. North America Humira Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Humira Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Humira Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Humira Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Humira Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Humira Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Humira Biosimilar Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Humira Biosimilar Sales Volume (%), (2019-2030)
Figure 39. United States Humira Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Humira Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Humira Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Humira Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 45. China Humira Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 47. China Humira Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Humira Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Humira Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Humira Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Humira Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Humira Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Humira Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 57. India Humira Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Humira Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 59. India Humira Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 60. Humira Biosimilar Industrial Chain
Figure 61. Humira Biosimilar Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232